1-way anova (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
1-way anova
1 Way Anova, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anova+(1-+or+2-way)+or+unpaired+t-test/1+way+anova/pmc12128067-38-5-12
Average 90 stars, based on 1 article reviews
1 Way Anova, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anova+(1-+or+2-way)+or+unpaired+t-test/1+way+anova/pmc12128067-38-5-12
Average 90 stars, based on 1 article reviews
1-way anova - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice. Article Snippet: Data were tested for normality and equal variance and analyzed by the appropriate parametric or nonparametric test (including unpaired 2-tailed t test, 1-way ANOVA with Tukey’s multiple comparison test, and 1-way ANOVA with Dunnett’s multiple comparison test) in Article Title: In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4. Article Snippet: A parametric, 2-tailed, unpaired Student t test or a 1-way ANOVA was performed with Article Title: Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms. Article Snippet: An atorvastatin calcium (AT)-loaded dextran sulfate (DXS)-coated core-shell reconstituted high density lipoprotein (rHDL), termed as AT-DXS-LP-rHDL, was developed for targeted drug delivery to macrophages and suppression of inflammation via the high affinity of DXS with scavenge receptor class AI (SR-AI) as well as depletion of intracellular cholesterol by apolipoprotein A-I (apoA-I)-mediated cholesterol efflux.. These core-shell nanoparticles comprising an AT-loaded negatively charged poly(lactide-co-glycolide) (PLGA) core and a cationic lipid bilayer shell, were prepared by nanoprecipitation method followed by thin film hydration and extrusion.. The nanoparticles were further functionalized with apoA-I and DXS via sodium cholate mediation and electrostatic interaction, respectively. |